rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1977-9-22
|
pubmed:abstractText |
The paper reports on intravenous and intrauterine application of Prostaglandin F2alpha and its 15-methyl derivative for the treatment of severe uterine bleedings in obsteterics and gynaecology. The effectiveness of the compounds is demonstrated.
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0016-5751
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
493-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:301838-Administration, Topical,
pubmed-meshheading:301838-Adolescent,
pubmed-meshheading:301838-Adult,
pubmed-meshheading:301838-Disseminated Intravascular Coagulation,
pubmed-meshheading:301838-Female,
pubmed-meshheading:301838-Humans,
pubmed-meshheading:301838-Injections, Intravenous,
pubmed-meshheading:301838-Obstetric Labor Complications,
pubmed-meshheading:301838-Postpartum Hemorrhage,
pubmed-meshheading:301838-Pregnancy,
pubmed-meshheading:301838-Prostaglandins F
|
pubmed:year |
1977
|
pubmed:articleTitle |
[Prostaglandin F2alpha- and 15-methyl-prostaglandin F2alpha-application for the treatment of severe uterine bleedings (author's transl)].
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|